Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells $713,986.86 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 35,951 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $19.86, for a total value of $713,986.86. Following the transaction, the insider directly owned 331,750 shares of the company’s stock, valued at $6,588,555. The trade was a 9.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Hyong Kim also recently made the following trade(s):

• On Wednesday, March 18th, Hyong Kim sold 18,404 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total value of $328,327.36.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $21.42 on Thursday. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. The stock has a fifty day moving average of $18.64 and a two-hundred day moving average of $19.44. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of 238.00, a PEG ratio of 2.78 and a beta of 1.14. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.Alignment Healthcare’s revenue was up 33.3% compared to the same quarter last year. During the same quarter last year, the business posted ($0.05) earnings per share. On average, analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently added to or reduced their stakes in the company. Summit Securities Group LLC purchased a new stake in Alignment Healthcare during the fourth quarter valued at about $26,000. Parallel Advisors LLC grew its position in Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC purchased a new stake in Alignment Healthcare during the third quarter valued at about $33,000. First Horizon Corp purchased a new stake in Alignment Healthcare during the fourth quarter valued at about $39,000. Finally, GAMMA Investing LLC grew its position in Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after acquiring an additional 987 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ALHC. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Zacks Research raised Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, April 28th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Wolfe Research began coverage on Alignment Healthcare in a research report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price objective for the company. Finally, Barclays lowered their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average price target of $24.30.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.